These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9131514)

  • 1. Managing corticosteroid induced osteoporosis in medical outpatients.
    Bell R; Carr A; Thompson P
    J R Coll Physicians Lond; 1997; 31(2):158-61. PubMed ID: 9131514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids.
    Mirzaei S; Zajicek HK; Knoll P; Hahn M; Levi M; Köhn H; Pohl W
    J Asthma; 2003 May; 40(3):251-5. PubMed ID: 12807168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is enough attention being given to the adverse effects of corticosteroid therapy?
    Hougardy DM; Peterson GM; Bleasel MD; Randall CT
    J Clin Pharm Ther; 2000 Jun; 25(3):227-34. PubMed ID: 10886467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis in steroid-dependent asthma.
    Villareal MS; Klaustermeyer WB; Hahn TJ; Gordon EH
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):369-72. PubMed ID: 8612121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T; Maekawa S; Morinobu S; Morinobu A; Koshiba M; Yamauchi M; Sugimoto T; Kumagai S
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.
    Soucy E; Bellamy N; Adachi JD; Pope JE; Flynn J; Sutton E; Campbell J
    J Rheumatol; 2000 Jun; 27(6):1506-12. PubMed ID: 10852279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
    van Staa TP; Leufkens HG; Cooper C
    Osteoporos Int; 2002 Oct; 13(10):777-87. PubMed ID: 12378366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis.
    Ho YV; Briganti EM; Duan Y; Buchanan R; Hall S; Seeman E
    Osteoporos Int; 1999; 9(2):134-8. PubMed ID: 10367040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroid use and bone-mineral density in patients with asthma.
    Wong CA; Walsh LJ; Smith CJ; Wisniewski AF; Lewis SA; Hubbard R; Cawte S; Green DJ; Pringle M; Tattersfield AE
    Lancet; 2000 Apr; 355(9213):1399-403. PubMed ID: 10791523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
    Walsh LJ; Lewis SA; Wong CA; Cooper S; Oborne J; Cawte SA; Harrison T; Green DJ; Pringle M; Hubbard R; Tattersfield AE
    Am J Respir Crit Care Med; 2002 Sep; 166(5):691-5. PubMed ID: 12204867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].
    Okada N
    Clin Calcium; 2004 Oct; 14(10):145-9. PubMed ID: 15577149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
    de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
    Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid-induced osteoporosis and bone mineral densimetry].
    Tanaka I; Oshima H
    Clin Calcium; 2004 Dec; 14(12):77-82. PubMed ID: 15577178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid-induced osteoporosis.
    Lucasey B
    Nurs Clin North Am; 2001 Sep; 36(3):455-66, ix. PubMed ID: 11532660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
    Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
    Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of quantitative ultrasound measurements as compared with dual-energy X-ray absorptiometry in the assessment of corticosteroid-induced bone impairment.
    Daens S; Peretz A; de Maertelaer V; Moris M; Bergmann P
    Osteoporos Int; 1999; 10(4):278-83. PubMed ID: 10692975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone concentrations in men on chronic glucocorticosteroid therapy.
    Fitzgerald RC; Skingle SJ; Crisp AJ
    J R Coll Physicians Lond; 1997; 31(2):168-70. PubMed ID: 9131516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician's awareness of the prevention of corticosteroid induced osteoporosis.
    Ungprasert S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):59-64. PubMed ID: 17621734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
    Tsugeno H; Tsugeno H; Fujita T; Goto B; Sugishita T; Hosaki Y; Ashida K; Mitsunobu F; Tanizaki Y; Shiratori Y
    Osteoporos Int; 2002 Aug; 13(8):650-6. PubMed ID: 12181624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.